In contrast, H19 functioned as a tumour suppressor in Wilms tumours61, adrenocortical carcinoma62, chronic myeloproliferative disorders26 and Li-Fraumeni syndrome osteosarcomas63. This evidence concerns the gene H19 and Li-Fraumeni syndrome.